Breaking News Instant updates and real-time market news.

CPB

Campbell Soup

$47.87 /

-0.15 (-0.31%)

05:18
02/26/20
02/26
05:18
02/26/20
05:18

Campbell Soup reinstated with a Neutral at Goldman Sachs

Goldman Sachs analyst Jason English reinstated coverage of Campbell Soup with a Neutral rating and $46 price target following the completion of the sale of Arnott's and other international businesses. The analyst believes Campbell's portfolio continues to face structural headwinds from the "shrinking center of the store," which he says remains a drag on the company's higher margin Meals and Beverages segment. However, these long-term headwinds are offset by near-term optimism on Campbell's fiscal 2020 growth prospects as the company benefits from share gains in soup, synergy savings and a "more benign" commodity backdrop in the second half of 2020, adds English.

  • 04

    Mar

CPB Campbell Soup
$47.87 /

-0.15 (-0.31%)

01/22/20
Campbell Soup initiated with a Hold at Jefferies
01/22/20 Jefferies
Campbell Soup initiated with a Hold at Jefferies
12/11/19 Deutsche Bank
Campbell Soup resumed with a Hold at Deutsche Bank
12/05/19 UBS
Campbell Soup price target raised to $41 from $36 at UBS

TODAY'S FREE FLY STORIES

Conference/Events
Ahold Delhaize management to meet virtually with Wolfe Research » 07:53
06/01/20
06/01
07:53
06/01/20
07:53
ADRNY

Ahold Delhaize

$0.00 /

+ (+0.00%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

05/28/20 Wolfe Research
Ahold Delhaize initiated with an Outperform at Wolfe Research
05/20/20 Morgan Stanley
Ahold Delhaize price target lowered to EUR 23.90 at Morgan Stanley
05/13/20 UBS
Ahold Delhaize downgraded to Sell from Neutral at UBS
04/28/20 Berenberg
Ahold Delhaize price target raised to EUR 20.20 from EUR 19.60 at Berenberg
ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

Downgrade
SVB Financial downgraded to Neutral from Buy at DA Davidson » 07:52
06/01/20
06/01
07:52
06/01/20
07:52
SIVB

SVB Financial

$214.72 /

-1.34 (-0.62%)

DA Davidson analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIVB SVB Financial
$214.72 /

-1.34 (-0.62%)

SIVB SVB Financial
$214.72 /

-1.34 (-0.62%)

06:46 Today DA Davidson
SVB Financial downgraded to Neutral from Buy at DA Davidson
04/27/20 SunTrust
SVB Financial price target raised to $210 from $165 at SunTrust
03/30/20 Wells Fargo
SVB Financial downgraded to Underweight from Equal Weight at Wells Fargo
03/30/20 Wells Fargo
SVB Financial downgraded to Underweight from Equal Weight at Wells Fargo
SIVB SVB Financial
$214.72 /

-1.34 (-0.62%)

Hot Stocks
Spero Therapeutics announces inducement grants under Nasdaq listing rule » 07:51
06/01/20
06/01
07:51
06/01/20
07:51
SPRO

Spero Therapeutics

$11.77 /

-0.09 (-0.76%)

Spero Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPRO Spero Therapeutics
$11.77 /

-0.09 (-0.76%)

SPRO Spero Therapeutics
$11.77 /

-0.09 (-0.76%)

05/11/20 H.C. Wainwright
Spero Therapeutics price target raised to $28 from $25 at H.C. Wainwright
11/05/19 H.C. Wainwright
Spero Therapeutics price target raised to $35 from $28 at H.C. Wainwright
10/03/19 Janney Montgomery Scott
Spero price target raised to $31 from $27 at Janney Montgomery Scott
10/02/19 Oppenheimer
Spero Therapeutics price target lowered to $20 from $30 at Oppenheimer
SPRO Spero Therapeutics
$11.77 /

-0.09 (-0.76%)

Recommendations
Allogene Therapeutics price target raised to $55 from $50 at Oppenheimer » 07:50
06/01/20
06/01
07:50
06/01/20
07:50
ALLO

Allogene Therapeutics

$48.08 /

+1.48 (+3.18%)

Oppenheimer analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

07:46 Today Raymond James
Allogene Therapeutics downgraded to Market Perform from Outperform at Raymond James
07:08 Today Goldman Sachs
Allogene Therapeutics price target raised to $66 from $45 at Goldman Sachs
06:48 Today JMP Securities
Allogene Therapeutics price target raised to $53 from $37 at JMP Securities
06:15 Today Raymond James
Allogene Therapeutics downgraded to Market Perform at Raymond James
ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

Periodicals
YouTube seeks TV advertising dollars despite obstacles, WSJ reports » 07:50
06/01/20
06/01
07:50
06/01/20
07:50
GOOG

Alphabet

$1,430.80 /

+14.43 (+1.02%)

, GOOGL

Alphabet Class A

$1,435.82 /

+17.61 (+1.24%)

YouTube is looking for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

Hot Stocks
Acreage Holdings enters two funding agreements for up to $60M gross proceeds » 07:50
06/01/20
06/01
07:50
06/01/20
07:50
ACRGF

Acreage Holdings

$0.00 /

+ (+0.00%)

Acreage Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRGF Acreage Holdings
$0.00 /

+ (+0.00%)

ACRGF Acreage Holdings
$0.00 /

+ (+0.00%)

02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
02/13/20 Cantor Fitzgerald
Acreage Holdings initiated with a Neutral at Cantor Fitzgerald
10/31/19 Ladenburg
Cannabis sector investor sentiment is now 'very low,' says Ladenburg
09/20/19 MKM Partners
MKM starts Acreage at Buy on 'extreme disconnect' from Canopy offer
ACRGF Acreage Holdings
$0.00 /

+ (+0.00%)

Conference/Events
Arcosa management to meet virtually with Oppenheimer » 07:50
06/01/20
06/01
07:50
06/01/20
07:50
ACA

Arcosa

$38.16 /

-0.12 (-0.31%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACA Arcosa
$38.16 /

-0.12 (-0.31%)

ACA Arcosa
$38.16 /

-0.12 (-0.31%)

03/20/20 DA Davidson
Arcosa price target lowered to $40 from $52 at DA Davidson
09/18/19 Sidoti
Arcosa initiated with a Buy at Sidoti
ACA Arcosa
$38.16 /

-0.12 (-0.31%)

ACA Arcosa
$38.16 /

-0.12 (-0.31%)

Initiation
Kala Pharmaceuticals assumed with an Outperform at Oppenheimer » 07:49
06/01/20
06/01
07:49
06/01/20
07:49
KALA

Kala Pharmaceuticals

$12.28 /

+0.04 (+0.33%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

05/27/20 JPMorgan
Kala Pharmaceuticals assumed with an Overweight at JPMorgan
05/27/20 H.C. Wainwright
Kala Pharmaceuticals price target raised to $17 from $14 at H.C. Wainwright
05/13/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Kala after 'underwhelming' competitor data
03/20/20 Wedbush
Kala Pharmaceuticals added to Best Ideas List at Wedbush
KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

KALA Kala Pharmaceuticals
$12.28 /

+0.04 (+0.33%)

Hot Stocks
Mayo Clinic joins Biomerica's InFoods IBS diagnostic-guided therapy trial » 07:48
06/01/20
06/01
07:48
06/01/20
07:48
BMRA

Biomerica Inc

$6.43 /

-0.08 (-1.23%)

Biomerica announced they…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRA Biomerica Inc
$6.43 /

-0.08 (-1.23%)

BMRA Biomerica Inc
$6.43 /

-0.08 (-1.23%)

Initiation
Pfenex assumed with an Outperform at Oppenheimer » 07:46
06/01/20
06/01
07:46
06/01/20
07:46
PFNX

Pfenex

$7.31 /

+0.48 (+7.03%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFNX Pfenex
$7.31 /

+0.48 (+7.03%)

PFNX Pfenex
$7.31 /

+0.48 (+7.03%)

04/23/20
Fly Intel: Top five analyst initiations
04/22/20 Oppenheimer
Pfenex initiated with an Outperform at Oppenheimer
04/22/20 Oppenheimer
Pfenex initiated with an Outperform at Oppenheimer
03/12/20 Cantor Fitzgerald
Pfenex risk/reward remains to the upside, says Cantor Fitzgerald
PFNX Pfenex
$7.31 /

+0.48 (+7.03%)

Recommendations
Nike price target raised to $110 from $85 at Cowen » 07:46
06/01/20
06/01
07:46
06/01/20
07:46
NKE

Nike

$98.47 /

+0.52 (+0.53%)

Cowen analyst John Kernan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$98.47 /

+0.52 (+0.53%)

NKE Nike
$98.47 /

+0.52 (+0.53%)

04/28/20 BTIG
Nike initiated with a Buy at BTIG
04/28/20 Piper Sandler
Nike estimates lowered after Adidas results at Piper Sandler
04/14/20 OTR Global
Nike cancels some orders for low-priority retailers, says OTR Global
04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens
NKE Nike
$98.47 /

+0.52 (+0.53%)

NKE Nike
$98.47 /

+0.52 (+0.53%)

NKE Nike
$98.47 /

+0.52 (+0.53%)

NKE Nike
$98.47 /

+0.52 (+0.53%)

Downgrade
Allogene Therapeutics downgraded to Market Perform from Outperform at Raymond James » 07:46
06/01/20
06/01
07:46
06/01/20
07:46
ALLO

Allogene Therapeutics

$48.08 /

+1.48 (+3.18%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

07:08 Today Goldman Sachs
Allogene Therapeutics price target raised to $66 from $45 at Goldman Sachs
06:48 Today JMP Securities
Allogene Therapeutics price target raised to $53 from $37 at JMP Securities
06:15 Today Raymond James
Allogene Therapeutics downgraded to Market Perform at Raymond James
05/29/20 H.C. Wainwright
Allogene Therapeutics price target raised to $55 from $42 at H.C. Wainwright
ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

Earnings
Edison Nation reaffirms 2020 revenue guidance $34M  07:46
06/01/20
06/01
07:46
06/01/20
07:46
EDNT

Edison Nation

$2.40 /

-0.115 (-4.57%)

 
ShowHide Related Items >><<
EDNT Edison Nation
$2.40 /

-0.115 (-4.57%)

EDNT Edison Nation
$2.40 /

-0.115 (-4.57%)

Earnings
Edison Nation reports preliminary Q1 revenue $3.6M vs. $5.8M last year » 07:45
06/01/20
06/01
07:45
06/01/20
07:45
EDNT

Edison Nation

$2.40 /

-0.115 (-4.57%)

The decrease in revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDNT Edison Nation
$2.40 /

-0.115 (-4.57%)

EDNT Edison Nation
$2.40 /

-0.115 (-4.57%)

Initiation
Otonomy assumed with an Outperform at Oppenheimer » 07:45
06/01/20
06/01
07:45
06/01/20
07:45
OTIC

Otonomy

$2.65 /

+0.06 (+2.32%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTIC Otonomy
$2.65 /

+0.06 (+2.32%)

OTIC Otonomy
$2.65 /

+0.06 (+2.32%)

05/07/20 Piper Sandler
Piper still believes in potential success of three key Otonomy programs
02/07/20 Piper Sandler
Otonomy should be bought ahead of near-term readouts, says Piper Sandler
12/24/19 Oppenheimer
Otonomy initiated with an Outperform at Oppenheimer
08/29/19 H.C. Wainwright
Otonomy initiated with a Buy at H.C. Wainwright
OTIC Otonomy
$2.65 /

+0.06 (+2.32%)

General news
Treasury Market Outlook: U.S. markets are little changed to begin June » 07:45
06/01/20
06/01
07:45
06/01/20
07:45

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Constellation Brands price target raised to $205 from $160 at Cowen » 07:44
06/01/20
06/01
07:44
06/01/20
07:44
STZ

Constellation Brands

$172.71 /

-2.69 (-1.53%)

Cowen analyst Vivien Azer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STZ Constellation Brands
$172.71 /

-2.69 (-1.53%)

STZ Constellation Brands
$172.71 /

-2.69 (-1.53%)

05/20/20 MKM Partners
MKM Partners sees negative pre-announcement as likely from Constellation Brands
05/08/20
Fly Intel: Top five analyst downgrades
05/08/20 MKM Partners
Constellation Brands double-downgraded to Sell from Buy at MKM Partners
05/08/20 MKM Partners
Constellation Brands downgraded to Sell from Buy at MKM Partners
STZ Constellation Brands
$172.71 /

-2.69 (-1.53%)

STZ Constellation Brands
$172.71 /

-2.69 (-1.53%)

STZ Constellation Brands
$172.71 /

-2.69 (-1.53%)

STZ Constellation Brands
$172.71 /

-2.69 (-1.53%)

Downgrade
AerCap downgraded to Neutral from Buy at BofA » 07:44
06/01/20
06/01
07:44
06/01/20
07:44
AER

AerCap

$32.28 /

-0.12 (-0.37%)

, AL

Air Lease

$30.19 /

-0.23 (-0.76%)

BofA analyst Ronald…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AER AerCap
$32.28 /

-0.12 (-0.37%)

AL Air Lease
$30.19 /

-0.23 (-0.76%)

AER AerCap
$32.28 /

-0.12 (-0.37%)

05/27/20 Stephens
AerCap shouldn't need capital markets funding until 2021, says Stephens
05/26/20 JPMorgan
JPMorgan upgrades Fly Leasing with stock rally lagging peers
05/06/20 Deutsche Bank
AerCap price target lowered to $44 from $63 at Deutsche Bank
05/06/20 Deutsche Bank
AerCap price target lowered to $44 from $63 at Deutsche Bank
AL Air Lease
$30.19 /

-0.23 (-0.76%)

05/26/20 JPMorgan
JPMorgan upgrades Fly Leasing with stock rally lagging peers
05/11/20 Deutsche Bank
Air Lease price target lowered to $36 from $45 at Deutsche Bank
AER AerCap
$32.28 /

-0.12 (-0.37%)

AL Air Lease
$30.19 /

-0.23 (-0.76%)

AER AerCap
$32.28 /

-0.12 (-0.37%)

AL Air Lease
$30.19 /

-0.23 (-0.76%)

AL Air Lease
$30.19 /

-0.23 (-0.76%)

AER AerCap
$32.28 /

-0.12 (-0.37%)

AL Air Lease
$30.19 /

-0.23 (-0.76%)

Earnings
Edison Nation reports FY19 EPS ($2.36) vs. ($1.28) last year » 07:44
06/01/20
06/01
07:44
06/01/20
07:44
EDNT

Edison Nation

$2.40 /

-0.115 (-4.57%)

Reports FY19 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDNT Edison Nation
$2.40 /

-0.115 (-4.57%)

Recommendations
Boston Beer price target raised to $650 from $570 at Cowen » 07:44
06/01/20
06/01
07:44
06/01/20
07:44
SAM

Boston Beer

$565.01 /

+21.56 (+3.97%)

Cowen analyst Vivien Azer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAM Boston Beer
$565.01 /

+21.56 (+3.97%)

SAM Boston Beer
$565.01 /

+21.56 (+3.97%)

05/28/20
Fly Intel: Top five analyst downgrades
05/28/20 Credit Suisse
Boston Beer downgraded to Neutral on valuation at Credit Suisse
05/28/20 Credit Suisse
Boston Beer downgraded to Neutral from Outperform at Credit Suisse
05/19/20 Deutsche Bank
Boston Beer price target raised to $481 from $409 at Deutsche Bank
SAM Boston Beer
$565.01 /

+21.56 (+3.97%)

SAM Boston Beer
$565.01 /

+21.56 (+3.97%)

SAM Boston Beer
$565.01 /

+21.56 (+3.97%)

Hot Stocks
Schultz Special Purpose reports LOI for combination with Clever Leaves » 07:44
06/01/20
06/01
07:44
06/01/20
07:44
SAMA

Schultz Special Purpose Acquisition

$10.19 /

+ (+0.00%)

Schultze Special Purpose…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Aerie Pharmaceuticals assumed with an Outperform at Oppenheimer » 07:43
06/01/20
06/01
07:43
06/01/20
07:43
AERI

Aerie Pharmaceuticals

$14.04 /

-0.2 (-1.40%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$14.04 /

-0.2 (-1.40%)

AERI Aerie Pharmaceuticals
$14.04 /

-0.2 (-1.40%)

05/07/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $31 from $37 at H.C. Wainwright
05/07/20 Mizuho
Aerie Pharmaceuticals price target lowered to $29 from $34 at Mizuho
05/07/20 Piper Sandler
Aerie Pharmaceuticals price target lowered to $35 from $45 at Piper Sandler
04/13/20 Mizuho
Aerie Pharmaceuticals price target lowered to $34 from $54 at Mizuho
AERI Aerie Pharmaceuticals
$14.04 /

-0.2 (-1.40%)

AERI Aerie Pharmaceuticals
$14.04 /

-0.2 (-1.40%)

Hot Stocks
Auxly Cannabis says established foundation to move towards positive cash flows » 07:42
06/01/20
06/01
07:42
06/01/20
07:42
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

Earnings
Auxly Cannabis reports Q1 EPS (C$0.02) vs (C$0.02) last year » 07:41
06/01/20
06/01
07:41
06/01/20
07:41
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

Reports Q1 net revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

Initiation
Delcath Systems initiated with a Buy at Laidlaw » 07:40
06/01/20
06/01
07:40
06/01/20
07:40
DCTH

Delcath Systems

$7.90 /

-0.235 (-2.89%)

Laidlaw analyst Yale Jen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCTH Delcath Systems
$7.90 /

-0.235 (-2.89%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.